Oncofactor Garners $2,100,000 Series A Financing Round

  • Feed Type
  • Date
    5/25/2011
  • Company Name
    Oncofactor
  • Mailing Address
    1616 Eastlake Ave. E. Seattle, WA 98102
  • Company Description
    Oncofactor is developing cancer therapeutics that disrupt signaling pathways between tumors and the immune system.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,100,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Specific proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    Alexandria Real Estate Equities
  • Venture Investor
    Amgen Ventures
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    PPD
  • Venture Investor
    WRF Capital

Next Post

Related Topics

Related Posts

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.